Quadramet®
SAMARIUM (153Sm) LEXIDRONAM PENTASODIUM
| Name | QUADRAMET® |
| Pharmaceutical form | Solution for injection |
| Nuclide | Samarium 153 |
| Half life | 46.3 hours |
| Composition | (153Sm-EDTMP) : 1.3 GBq/mL (at calibration date) (Corresponding to 20 to 46 µg/mL of samarium) |
| Available activities | 2 to 4 GBq per vial at calibration date |
| Posology and method of administration |
• 37 MBq per kg body weight • Slow intravenous route through an established intravenous line over a period of one minute • Should not be diluted before use |
| Availability and Calibration | On Monday calibrated Thursday 12 a.m. On Friday calibrated Monday 12 a.m. |
| Ordering deadline | 1 day before the shipment day, before 11 a.m. |
| Expiry | 4 days from the manufacturing date |
| Storage | • Delivered frozen in dry ice, should be stored frozen at -10°C to -20°C in its original packaging • Use within 6 hours of thawing • After thawing, do not freeze again |
| Indication | Relief of bone pain in patients with multiple painful osteoblastic skeletal metastases which take up technetium (99mTc)-labelled biphosphonates on bone scan |
Support Solution
IBA does not provide pharmaceuticals... we do much more than that. Beyond the quality of our products and services you expect a leading radiopharmaceutical company to provide you with all the environment necessary to master our products and to operate your daily activity in a professional manner.
Our set of customer solutions includes :
- Product trainings
- Round tables facilitation
- Patient recruitment support
- ISS (Investigator Sponsored Studies)
- Organisations of symposiums
- Newsletters
Product Calendar
SPC
For all other countries, please contact your local representative.
